Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CR.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
CR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.258.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.258.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.225EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.225EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.225ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.225ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.225EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.225EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.225ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.225ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.2.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
A.2.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.2.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.2.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AV.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AV.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AV.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AV.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.309EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.309EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.309ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.309ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.309EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.309EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.309ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.309ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.105EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.105EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.105ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.105ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.105EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.105EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.105ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.105ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used